Skip to main content
Trillium Therapeutics Inc. logo

Trillium Therapeutics Inc. — Investor Relations & Filings

Ticker · TRIL TSX Professional, scientific and technical activities
Filings indexed 76 across all filing types
Latest filing 2021-11-17 Regulatory Filings
Country CA Canada
Listing TSX TRIL

About Trillium Therapeutics Inc.

http://www.trilliumtherapeutics.com

Trillium Therapeutics Inc. was a clinical-stage biopharmaceutical company specializing in immuno-oncology. The company focused on the discovery and development of innovative therapies for the treatment of cancer, particularly those targeting the immune system and its regulation. Trillium maintained preclinical programs and advanced several candidates through clinical trials in the oncology therapy area. In November 2021, Trillium Therapeutics was acquired by Pfizer Inc. and now operates as an integrated entity within Pfizer's global biopharmaceutical research and development structure, continuing its focus on advancing cancer treatments.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings
2021-11-17 English
News release - English.pdf
Regulatory Filings
2021-11-17 English
Other.pdf
Regulatory Filings
2021-11-16 English
Other.pdf
Regulatory Filings
2021-11-16 English
Other.pdf
Regulatory Filings
2021-10-29 English
Report of voting results.pdf
Regulatory Filings
2021-10-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.